These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15549773)

  • 1. Effector and regulatory T cells derived from the same T cell clone differ in MHC class II-peptide multimer binding.
    Nolte-'t Hoen EN; Amoroso MG; Veenstra J; Grosfeld-Stulemeyer MC; van Eden W; Broeren CP; Wauben MH
    Eur J Immunol; 2004 Dec; 34(12):3359-69. PubMed ID: 15549773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes.
    Kropshofer H; Spindeldreher S; Röhn TA; Platania N; Grygar C; Daniel N; Wölpl A; Langen H; Horejsi V; Vogt AB
    Nat Immunol; 2002 Jan; 3(1):61-8. PubMed ID: 11743588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rafting MHC-II domains in the APC (presynaptic) plasma membrane and the thresholds for T-cell activation and immunological synapse formation.
    Gombos I; Detre C; Vámosi G; Matkó J
    Immunol Lett; 2004 Mar; 92(1-2):117-24. PubMed ID: 15081535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of MHC class II tetramers to investigate CD4+ T cell responses: problems and solutions.
    Cecconi V; Moro M; Del Mare S; Dellabona P; Casorati G
    Cytometry A; 2008 Nov; 73(11):1010-8. PubMed ID: 18612991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-mediated presentation of MHC class II molecules guides thymocytes to the CD4 lineage.
    Komaniwa S; Hayashi H; Kawamoto H; Sato SB; Ikawa T; Katsura Y; Udaka K
    Eur J Immunol; 2009 Jan; 39(1):96-112. PubMed ID: 19089815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of low-frequency human antigen-specific CD4(+) T cells using MHC class II multimer bead sorting and immunoscope analysis.
    Lemaître F; Viguier M; Cho MS; Fourneau JM; Maillère B; Kourilsky P; Van Endert PM; Ferradini L
    Eur J Immunol; 2004 Oct; 34(10):2941-9. PubMed ID: 15368300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting cytoskeletal regulation of MHC class II peptide presentation by human B cells or dendritic cells.
    Delaguillaumie A; Marin-Esteban V; Setterblad N; Leh LJ; Assier E; Gelin C; Charron D; Galy A; Mooney N
    Eur J Immunol; 2008 Apr; 38(4):1096-105. PubMed ID: 18393378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation.
    Anderson HA; Hiltbold EM; Roche PA
    Nat Immunol; 2000 Aug; 1(2):156-62. PubMed ID: 11248809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Location of major histocompatibility complex class II molecules in rafts on dendritic cells enhances the efficiency of T-cell activation and proliferation.
    Eren E; Yates J; Cwynarski K; Preston S; Dong R; Germain C; Lechler R; Huby R; Ritter M; Lombardi G
    Scand J Immunol; 2006 Jan; 63(1):7-16. PubMed ID: 16398696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
    Kobayashi H; Nagato T; Takahara M; Sato K; Kimura S; Aoki N; Azumi M; Tateno M; Harabuchi Y; Celis E
    Cancer Res; 2008 Feb; 68(3):901-8. PubMed ID: 18245493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent induction of distinct anergic phenotypes: multiple levels of T cell anergy.
    Taams LS; van Eden W; Wauben MH
    J Immunol; 1999 Feb; 162(4):1974-81. PubMed ID: 9973467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC class II-mediated antigen presentation by alloreactive rat CD4+ T cells does not induce regulatory properties.
    Otto C; Heeg A; Kottenmeier S; Tiurbe GC; Thiede A; Ulrichs K
    Transplant Proc; 2006 Apr; 38(3):755-6. PubMed ID: 16647463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformation of MHC class II I-A(g7) is sensitive to the P9 anchor amino acid in bound peptide.
    Gardiner A; Richards KA; Sant AJ; Arneson LS
    Int Immunol; 2007 Sep; 19(9):1103-13. PubMed ID: 17855434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting TCR-MHC/peptide complex interactions with A2/peptide multimers incorporating tumor antigen peptide variants: crucial role of interaction kinetics on functional outcomes.
    Dutoit V; Guillaume P; Cerottini JC; Romero P; Valmori D
    Eur J Immunol; 2002 Nov; 32(11):3285-93. PubMed ID: 12555674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol and sphingolipids as lipid organizers of the immune cells' plasma membrane: their impact on the functions of MHC molecules, effector T-lymphocytes and T-cell death.
    Gombos I; Kiss E; Detre C; László G; Matkó J
    Immunol Lett; 2006 Apr; 104(1-2):59-69. PubMed ID: 16388855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide binding inhibits aggregation of soluble MHC class II in solution.
    Arimilli S; Astafieva I; Mukku PV; Cardoso C; Deshpande S; Nag B
    IUBMB Life; 1999 Nov; 48(5):483-91. PubMed ID: 10637763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited plasticity in T cell recognition of modified T cell receptor contact residues in MHC class II bound peptides.
    de Haan EC; Wagenaar-Hilbers JP; Liskamp RM; Moret EE; Wauben MH
    Mol Immunol; 2005 Feb; 42(3):355-64. PubMed ID: 15589324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functionally divergent T lymphocyte responses induced by modification of a self-peptide from a tumor-associated antigen.
    Hess AD; Thoburn CJ; Miura Y; Bright EC
    Clin Immunol; 2005 Mar; 114(3):307-19. PubMed ID: 15721842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of retinal pigmented epithelial cells and CD4 T cells leads to T-cell anergy.
    Gregerson DS; Heuss ND; Lew KL; McPherson SW; Ferrington DA
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4654-63. PubMed ID: 17898289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes.
    Schjetne KW; Thommesen JE; Fredriksen AB; Lunde E; Sandlie I; Bogen B
    Eur J Immunol; 2005 Nov; 35(11):3142-52. PubMed ID: 16184515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.